Axon Enterprise, Inc. is set to release second-quarter 2026 results after the market closes on Aug. 5, giving Axon Stock a date on the calendar that could move it quickly. Wall Street expects revenue of $868.4 million and earnings of $1.89 per share.
That revenue view points to growth of 29.9% from a year earlier, while the earnings estimate is down 10.9% from the same quarter last year. The stock has already climbed 22.5% over the past six months, so traders are not walking into this report with low expectations.
The company’s latest quarter is being watched closely because the two main businesses are still doing the heavy lifting. The Connected Devices segment is expected to benefit from demand for TASER 10 products, higher cartridge revenues, strong interest in Axon Body 4, virtual reality training services and strength in counter-drone work. Its revenue is projected at $479 million, up 27.4% from a year earlier. Software & Services is also expected to add to the result, helped by new users and associated devices on the AXON network, along with digital evidence management and premium add-on features. That segment is projected to post $390 million in sales, up 33.6% year over year.
There is still a catch. The earnings estimate has not moved in 60 days, and Axon Enterprise has an Earnings ESP of 0.00%, a reading that leaves no cushion above the consensus mark. The company has beaten estimates in two of the past four quarters, missed in the other two, and averaged an 8.8% surprise. In the last reported quarter, it earned $1.61 per share and missed the consensus by 3%. Axon currently carries a Zacks Rank of 3, and while its shares have outpaced the broader defense equipment group over the past six months, the next move will likely depend on whether the quarter delivers enough growth to justify the run.
Axon Enterprise’s February 2026 purchase of Carbyne also hangs over the report. The deal folded cloud-native 911 technology into the Axon ecosystem to create Axon 911, and that kind of integration can help revenue, but it also adds cost. Business integration spending, higher wages and stock-based compensation are expected to pressure the bottom line, which makes Aug. 5 less about what Axon has sold and more about how much of that growth it can keep.
For Axon shareholders, the real test arrives after the closing bell on Aug. 5: whether the company can turn strong demand across devices and software into a result that clears the $1.89 consensus and extends the stock’s run.
